|
|
|
Insider
Information: |
Bradsher Neal C |
Relationship: |
10% Owner |
City: |
Union City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
129,185 |
|
Indirect Shares
|
57,363,752 |
|
|
Direct
Value |
$1,186,888 |
|
|
Indirect Value
|
$499,113,789 |
|
|
Total
Shares |
57,492,937 |
|
|
Total
Value |
$500,300,677 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
60
|
50
|
Stock
price went up :
|
44
|
16
|
Stock
price went down : |
16
|
34
|
|
|
|
Gain/Loss Ratio : |
2.8
|
2.8
|
Percentage
Gain/Loss : |
10.9%
|
-929.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Questcor Pharmaceuticals Inc |
QCOR |
Director |
2014-08-14 |
0 |
2014-08-14 |
0 |
Premium* |
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director, 10% Owner |
2024-02-06 |
87,628 |
2024-02-06 |
41,666,255 |
Premium* |
|
Comarco Inc |
CMRO |
10% Owner |
2017-09-15 |
15,500 |
2017-09-15 |
0 |
Premium* |
|
STAAR Surgical Co |
STAA |
10% Owner |
2024-05-09 |
25,900 |
2024-05-09 |
10,768,431 |
Premium* |
|
Palomar Medical Technologies Inc |
PMTI |
10% Owner |
2013-06-24 |
0 |
2013-06-24 |
0 |
Premium* |
|
Asterias Biotherapeutics Inc |
AST |
See Remarks Below |
2019-03-08 |
0 |
2019-03-08 |
0 |
Premium* |
|
Oncocyte Corp |
OCX |
10% Owner |
2024-04-11 |
157 |
2024-04-11 |
4,929,066 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
612 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 22 of 25
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
STAA |
STAAR Surgical Co |
10% Owner |
|
2015-08-24 |
4 |
B |
$7.20 |
$883,008 |
D/D |
122,577 |
8,290,959 |
2.45 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2014-11-03 |
4 |
B |
$9.23 |
$1,134,318 |
D/D |
122,900 |
7,093,436 |
2.45 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2005-11-02 |
4 |
B |
$0.80 |
$98,135 |
I/I |
123,100 |
2,718,360 |
2.1 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2013-11-11 |
4 |
S |
$62.25 |
$8,099,795 |
D/D |
(130,122) |
3,166,538 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2013-06-14 |
4 |
S |
$46.06 |
$6,080,567 |
D/D |
(132,000) |
3,296,660 |
0 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2023-09-20 |
4 |
B |
$40.67 |
$5,372,274 |
D/D |
132,079 |
9,109,613 |
2.45 |
% |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2012-08-01 |
4 |
B |
$5.16 |
$688,590 |
D/D |
133,572 |
6,352,603 |
2.45 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2006-05-15 |
4 |
A |
$1.51 |
$203,405 |
I/I |
135,000 |
2,953,360 |
|
- |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2006-05-15 |
4/A |
B |
$1.51 |
$203,405 |
I/I |
135,000 |
2,953,360 |
2.1 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2012-07-31 |
4 |
B |
$5.11 |
$711,753 |
D/D |
139,300 |
6,219,031 |
2.45 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2015-09-25 |
4 |
B |
$7.07 |
$1,002,039 |
D/D |
141,651 |
8,448,114 |
2.45 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2016-05-12 |
4 |
B |
$5.65 |
$813,463 |
D/D |
143,935 |
10,561,605 |
2.45 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2023-11-02 |
4 |
B |
$35.64 |
$5,155,243 |
D/D |
144,027 |
9,613,750 |
2.45 |
% |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2021-02-08 |
4 |
S |
$122.28 |
$17,710,791 |
D/D |
(144,838) |
9,646,623 |
0 |
% |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2013-06-13 |
4 |
S |
$45.24 |
$6,785,430 |
D/D |
(150,000) |
3,428,660 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2017-07-31 |
4 |
B |
$2.80 |
$420,000 |
D/D |
150,000 |
27,269,254 |
3.92 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2023-09-21 |
4 |
B |
$39.62 |
$6,133,467 |
D/D |
154,814 |
9,264,427 |
2.45 |
% |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2024-01-05 |
4 |
B |
$28.48 |
$4,463,231 |
D/D |
156,734 |
10,764,388 |
2.45 |
% |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2023-11-29 |
4 |
B |
$31.38 |
$5,031,358 |
D/D |
160,300 |
10,360,128 |
2.45 |
% |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2023-11-06 |
4 |
B |
$34.16 |
$5,623,518 |
D/D |
164,607 |
9,778,877 |
2.45 |
% |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2021-01-27 |
4 |
S |
$103.99 |
$17,125,697 |
D/D |
(164,686) |
10,178,219 |
0 |
% |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2013-11-13 |
4 |
S |
$62.56 |
$10,886,801 |
D/D |
(174,034) |
2,796,660 |
0 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2023-11-30 |
4 |
B |
$31.42 |
$5,583,678 |
D/D |
177,707 |
10,537,835 |
2.45 |
% |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2013-11-12 |
4 |
S |
$62.28 |
$12,197,243 |
D/D |
(195,844) |
2,970,694 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
Director |
|
2006-12-13 |
4 |
B |
$1.45 |
$290,000 |
I/I |
200,000 |
3,153,360 |
2.1 |
- |
|
612 Records found
|
|
Page 22 of 25 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|